Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission

Christoph J Schlimp, Wolfgang Voelckel, Kenji Inaba, Marc Maegele, Martin Ponschab, Herbert Schöchl, Christoph J Schlimp, Wolfgang Voelckel, Kenji Inaba, Marc Maegele, Martin Ponschab, Herbert Schöchl

Abstract

Introduction: Fibrinogen plays a key role in hemostasis and is the first coagulation factor to reach critical levels in massively bleeding trauma patients. Consequently, rapid estimation of plasma fibrinogen (FIB) is essential upon emergency room (ER) admission, but is not part of routine coagulation monitoring in many centers. We investigated the predictive ability of the laboratory parameters hemoglobin (Hb) and base excess (BE) upon admission, as well as the Injury Severity Score (ISS), to estimate FIB in major trauma patients.

Methods: In this retrospective study, major trauma patients (ISS ≥16) with documented FIB analysis upon ER admission were eligible for inclusion. FIB was correlated with Hb, BE and ISS, alone and in combination, using regression analysis.

Results: A total of 675 patients were enrolled (median ISS 27). FIB upon admission correlated strongly with Hb, BE and ISS. Multiple regression analysis showed that Hb and BE together predicted FIB (adjusted R2 = 0.46; loge(FIB) = 3.567 + 0.223.Hb - 0.007.Hb2 + 0.044.BE), and predictive strength increased when ISS was included (adjusted R2 = 0.51; loge(FIB) = 4.188 + 0.243.Hb - 0.008.Hb2 + 0.036.BE - 0.031.ISS + 0.0003.ISS2). Of all major trauma patients admitted with Hb <12 g/dL, 74% had low (<200 mg/dL) FIB and 54% had critical (<150 mg/dL) FIB. Of patients admitted with Hb <10 g/dL, 89% had low FIB and 73% had critical FIB. These values increased to 93% and 89%, respectively, among patients with an admission Hb <8 g/dL. Sixty-six percent of patients with only a weakly negative BE (<-2 mmol/L) showed low FIB. Of patients with BE <-6 mmol/L upon admission, 81% had low FIB and 63% had critical FIB. The corresponding values for BE <-10 mmol/L were 89% and 78%, respectively.

Conclusions: Upon ER admission, FIB of major trauma patients shows strong correlation with rapidly obtainable, routine laboratory parameters such as Hb and BE. These two parameters might provide an insightful and rapid tool to identify major trauma patients at risk of acquired hypofibrinogenemia. Early calculation of ISS could further increase the ability to predict FIB in these patients. We propose that FIB can be estimated during the initial phase of trauma care based on bedside tests.

Figures

Figure 1
Figure 1
Correlation between FIB and Hb, BE or ISS. Plasma fibrinogen concentration (FIB, mg/dL) versus (A) hemoglobin (Hb, g/dL), (B) base excess (BE, mmol/L) and (C) Injury Severity Score (ISS). The fitted regression line (solid) is shown along with a corresponding 95% confidence interval (dotted lines).
Figure 2
Figure 2
FIB stratified according to different categories of Hb, BE and ISS. Plasma fibrinogen concentration (FIB, mg/dL) stratified according to (A) hemoglobin (Hb, g/dL), (B) base excess (BE, mmol/L) and (C) Injury Severity Score (ISS).***P <0.001. Boxes indicate the range between the 25th and 75th percentile, whiskers represent the range between the 5th and 95th percentile, horizontal lines represents the median, and black circles represent outliers. Yellow areas represents FIB values between 199 and 150 mg/dL, red areas indicates FIB values below 150 mg/dL.
Figure 3
Figure 3
Combined admission variables resulting in a median plasma fibrinogen level (FIB, mg/dL). (A) Hemoglobin (Hb, g/dL) and base excess (BE, mmol/L), (B) Injury Severity Score (ISS) and Hb, and (C) ISS and BE. Green columns indicate adequate FIB (≥200 mg/dL), yellow columns indicate low FIB (<200 mg/dL), and red columns indicate critical FIB (<150 mg/dL).
Figure 4
Figure 4
Percentage of patients with adequate, low and critical FIB stratified according to Hb and BE. Observed percentage of patients with adequate plasma fibrinogen concentration (FIB) (≥200 mg/dL, green), low FIB (199 to 150 mg/dL, yellow) and critical FIB (<150 mg/dL, red) when combining the admission variables hemoglobin (Hb, g/dL) and base excess (BE, mmol/L).
Figure 5
Figure 5
Percentage of patients with adequate, low and critical FIB stratified according to ISS and BE. Observed percentage of patients with adequate plasma fibrinogen concentration (FIB) (≥200 mg/dL, green), low FIB (199 to 150 mg/dL, yellow) and critical FIB (<150 mg/dL, red) when combining the admission variables Injury Severity Score (ISS) and base excess (BE, mmol/L).
Figure 6
Figure 6
Percentage of patients with adequate, low and critical FIB stratified according to ISS and Hb. Observed percentage of patients with adequate plasma fibrinogen concentration (FIB) (≥200 mg/dL, green), low FIB (199 to 150 mg/dL, yellow) and critical FIB (<150 mg/dL, red) when combining the admission variables Injury Severity Score (ISS) and hemoglobin (Hb, g/dL).

References

    1. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;17:1127–1130. doi: 10.1097/01.TA.0000069184.82147.06.
    1. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;17:298–304. doi: 10.1016/j.injury.2006.10.003.
    1. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;17:360–365.
    1. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol. Am J Clin Pathol. 2011;17:364–370. doi: 10.1309/AJCPH16YXJEFSHEO.
    1. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;17:851–863. doi: 10.1093/bja/aes361.
    1. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;17:1894–1904. doi: 10.1111/j.1538-7836.2005.01365.x.
    1. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;17:137–144.
    1. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sorensen B, Hagl C, Pichlmaier M. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology. 2013;17:40–50. doi: 10.1097/ALN.0b013e3182715d4d.
    1. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D. PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;17:266–273. doi: 10.1111/j.1538-7836.2007.02297.x.
    1. Schochl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, Solomon C. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care. 2011;17:R265. doi: 10.1186/cc10539.
    1. Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth. 2011;17:378–387. doi: 10.1093/bja/aer158.
    1. Inaba K, Karamanos E, Lustenberger T, Schochl H, Shulman I, Nelson J, Rhee P, Talving P, Lam L, Demetriades D. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg. 2013;17:290–297. doi: 10.1016/j.jamcollsurg.2012.10.017.
    1. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, Wolf SE, Wade CE, Holcomb JB. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;17:S79–85.
    1. Schochl H, Forster L, Woidke R, Solomon C, Voelckel W. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia. 2010;17:199–203. doi: 10.1111/j.1365-2044.2009.06188.x.
    1. Schochl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;17:R83. doi: 10.1186/cc10078.
    1. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;17:1342–1351. doi: 10.1111/j.1538-7836.2012.04752.x.
    1. Ziegler B, Schimke C, Marchet P, Stogermuller B, Schochl H, Solomon C. Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets. Clin Appl Thromb Hemost. 2013;17:453–9. doi: 10.1177/1076029612458149.
    1. Wafaisade A, Lefering R, Maegele M, Brockamp T, Mutschler M, Lendemans S, Banerjee M, Bouillon B, Probst C. Trauma Registry of DGU. Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge. J Trauma Acute Care Surg. 2013;17:387–395. doi: 10.1097/TA.0b013e31827e2410.
    1. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;17:R76. doi: 10.1186/cc12685.
    1. Schöchl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;17:125–131. doi: 10.1097/TA.0b013e31818b2483.
    1. Schochl H, Solomon C, Traintinger S, Nienaber U, Tacacs-Tolnai A, Windhofer C, Bahrami S, Voelckel W. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma. 2011;17:2033–2041. doi: 10.1089/neu.2010.1744.
    1. Schochl H, Maegele M, Solomon C, Gorlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012;17:15. doi: 10.1186/1757-7241-20-15.
    1. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost. 2009;17:394–401.
    1. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009;17:1097–1102. doi: 10.1111/j.1471-0528.2009.02187.x.
    1. Frith D, Goslings JC, Gaarder C, Maegele M, Cohen MJ, Allard S, Johansson PI, Stanworth S, Thiemermann C, Brohi K. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost. 2010;17:1919–1925. doi: 10.1111/j.1538-7836.2010.03945.x.
    1. Lier H, Bottiger BW, Hinkelbein J, Krep H, Bernhard M. Coagulation management in multiple trauma: a systematic review. Intensive Care Med. 2011;17:572–582. doi: 10.1007/s00134-011-2139-y.
    1. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate--a potential universal hemostatic agent. Expert Opin Biol Ther. 2009;17:1325–1333. doi: 10.1517/14712590903193051.
    1. Corum LE, Hlady V. The effect of upstream platelet-fibrinogen interactions on downstream adhesion and activation. Biomaterials. 2012;17:1255–1260. doi: 10.1016/j.biomaterials.2011.10.074.
    1. Cohen MJ, Kuttcher M, Redick B, on behalf of the PROMMTT study group. Clinical and mechanistics drivers of acute traumatic coagulopathy. J Trauma. in press .
    1. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;17:2652–2658.
    1. Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Négrier C, Allaouchiche B. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;17:26–32. doi: 10.1016/j.injury.2010.11.003.
    1. Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schochl H. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus. 2012. pp. 1–9.
    1. Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb JB. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma. 2005;17:1002–1009. doi: 10.1097/01.TA.0000156246.53383.9F.
    1. White NJ, Martin EJ, Brophy DF, Ward KR. Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation. 2010;17:111–116. doi: 10.1016/j.resuscitation.2009.09.017.
    1. Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, Zaydfudim V, Johnston M, Arbogast P, Young PP. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010;17:S33–39.
    1. Schochl H, Voelckel W, Maegele M, Solomon C. Trauma-associated hyperfibrinolysis. Hamostaseologie. 2012;17:22–27.
    1. Solomon C, Cadamuro J, Ziegler B, Schochl H, Varvenne M, Sorensen B, Hochleitner G, Rahe-Meyer N. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion. 2011;17:1695–1706. doi: 10.1111/j.1537-2995.2011.03066.x.
    1. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis. 1995;17:743–746. doi: 10.1097/00001721-199512000-00008.
    1. Adam S, Karger R, Kretschmer V. Photo-optical methods can lead to clinically relevant overestimation of fibrinogen concentration in plasma diluted with hydroxyethyl starch. Clin Appl Thromb Hemost. 2010;17:461–471. doi: 10.1177/1076029609342090.
    1. Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost. 2010;17:454–460. doi: 10.1177/1076029609336855.
    1. Fries D, Innerhofer P, Reif C, Streif W, Klingler A, Schobersberger W, Velik-Salchner C, Friesenecker B. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg. 2006;17:347–351. doi: 10.1213/01.ane.0000194359.06286.d4.
    1. Grottke O, Braunschweig T, Henzler D, Coburn M, Tolba R, Rossaint R. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care. 2010;17:R62. doi: 10.1186/cc8960.
    1. Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth. 2012;17:135–137. doi: 10.1093/bja/aes227.
    1. Fries D. Fibrinogen concentrate (FGTW) in trauma patients, presumed to bleed (FI in TIC) 2013. Accessed June 21.
    1. Singbartl K, Innerhofer P, Radvan J, Westphalen B, Fries D, Stogbauer R, Van Aken H. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg. 2003;17:929–935.
    1. Baker SP, O'Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;17:187–196. doi: 10.1097/00005373-197403000-00001.

Source: PubMed

3
Abonneren